Tata Elxsi and Dräger collaborate to drive critical care innovation in India
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
Under the arrangement, Dr. Reddy's will have exclusive rights to promote and distribute Sanofi's vaccine brands Hexaxim, Pentaxim, Tetraxim, Menactra, FluQuadri, Adacel and Avaxim 80U
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
Centhaquine is a resuscitative agent presently indicated for the treatment of hypovolemic shock by DGCI
The MDC business produces components for medical device manufacturers globally with a focus on precious metal alloys and nitinol
Lonza plans to invest approximately CHF 500 million to upgrade the facility
Both organisations enter into a long- term collaboration to expand patient access in India
Strategic multi-year research collaboration to identify novel targets with strong disease links and to accelerate clinical development
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Anand is committed to leading the company's continued commitment to driving innovation in Health Care through the utilization of Digital transformation, AI and LLM
Subscribe To Our Newsletter & Stay Updated